[Bacteremia caused by Streptococcus equisimilis in a neoplastic patient treated with recombinant interleukin 2].
Pedro-Botet
M L
ML
Ribelles Entrena
N
N
Carrasco Miserachs
I
I
Carles Galcerán
J
J
Sabria-Leal
M
M
Arnal
J
J
D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D018805:Sepsis / Q000209:etiology*; D013290:Streptococcal Infections / Q000209:etiology*
D007376:Interleukin-2; D011994:Recombinant Proteins
Bacteriemia por Streptococcus equisimilis en un paciente neoplásico tratado con interleucina-2 recombinante.